You are here: Industry Insights > Acquisition

News List

Fresenius makes a flurry of deals in Chinese dialysis clinics and hospitals fiercebiotech
December 29, 2018
Fresenius Medical Care has moved to dramatically widen its footprint in China’s dialysis market, acquiring large shares in multiple Chinese companies and hospital systems across the country.....
3P Biopharmaceuticals Completes Facility Expansion contractpharma
December 27, 2018
3P Biopharmaceuticals, a contract development and manufacturing organization (CDMO) specialized in the process development and GMP production of biologics, has completed the project for the expansion
Roivant strikes broad pipeline pact with Daiichi fiercebiotech
December 25, 2018
Roivant has secured an option to license a stream of drugs from Daiichi Sankyo. The deal is the first time Roivant has formed a framework to facilitate the ongoing in-licensing of drugs from a company rather than picked up assets on an ad hoc basis.....
Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical to Purchase UPSA americanpharmaceuticalreview
December 24, 2018
Bristol-Myers Squibb announced that Taisho Pharmaceutical has offered to purchase Bristol-Myers Squibb’s UPSA consumer health business for $1.6 billion....
Therapix Biosciences Terminates FSD Acquisition Letter of Intent americanpharmaceuticalreview
December 24, 2018
Therapix Biosciences, a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments.....
Novartis makes offer to acquire French CDMO CellforCure pharmaceutical-technology
December 24, 2018
Novartis has made an offer to acquire CellforCure, a France-based contract development and manufacturing organisation (CDMO) producing cell and gene therapies in Europe, from LFB for an undisclosed amount.....
Astellas Pharma, Taisho Pharmaceuticals, AMAG Pharmaceuticals pharmaceutical-technology
December 24, 2018
Astellas Pharma has completed the acquisition of Potenza Therapeutics for $405m.Astellas made an upfront payment of $164.6m and has agreed to...
BMS confirms Taisho’s $1.6bn offer for UPSA pharmaphorum
December 21, 2018
After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA to Japan’s Taisho Pharma in a $1.6 billion deal.
Japan’s Taisho offers to acquire Bristol-Myer’s UPSA for $1.6bn pharmaceutical-technology
December 21, 2018
Japan-based Taisho Pharmaceutical has offered to acquire US-based Bristol-Myers Squibb’s UPSA consumer health business for $1.6bn.....
Alcon Announces Acquisition of Tear Film Innovations americanpharmaceuticalreview
December 20, 2018
Alcon has acquired Tear Film Innovations, a privately-held company and manufacturer of the iLux Device, a therapeutic device used to treat Meibomian Gland Dysfunction, a leading cause of dry eye.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page